Literature DB >> 20012109

Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis.

Richard A Armstrong1, William Ellis, Ronald L Hamilton, Ian R A Mackenzie, John Hedreen, Marla Gearing, Thomas Montine, Jean-Paul Vonsattel, Elizabeth Head, Andrew P Lieberman, Nigel J Cairns.   

Abstract

Studies suggest that frontotemporal lobar degeneration with transactive response DNA-binding protein of 43 kDa (TDP-43) proteinopathy (FTLD-TDP) is heterogeneous with division into four or five subtypes. To determine the degree of heterogeneity and the validity of the subtypes, we studied neuropathological variation within the frontal and temporal lobes of 94 cases of FTLD-TDP using quantitative estimates of density and principal components analysis (PCA). A PCA based on the density of TDP-43 immunoreactive neuronal cytoplasmic inclusions, oligodendroglial inclusions, neuronal intranuclear inclusions, and dystrophic neurites, surviving neurons, enlarged neurons, and vacuolation suggested that cases were not segregated into distinct subtypes. Variation in the density of the vacuoles was the greatest source of variation between cases. A PCA based on TDP-43 pathology alone suggested that cases of FTLD-TDP with progranulin (GRN) mutation segregated to some degree. The pathological phenotype of all four subtypes overlapped but subtypes 1 and 4 were the most distinctive. Cases with coexisting motor neuron disease (MND) or hippocampal sclerosis (HS) also appeared to segregate to some extent. We suggest: (1) pathological variation in FTLD-TDP is best described as a 'continuum' without clearly distinct subtypes, (2) vacuolation was the single greatest source of variation and reflects the 'stage' of the disease, and (3) within the FTLD-TDP 'continuum' cases with GRN mutation and with coexisting MND or HS may have a more distinctive pathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20012109      PMCID: PMC2830004          DOI: 10.1007/s00702-009-0350-6

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  40 in total

1.  Spatial correlations between the vacuolation, prion protein deposits, and surviving neurons in the cerebral cortex in sporadic Creutzfeldt-Jakob disease.

Authors:  R A Armstrong; P L Lantos; N J Cairns
Journal:  Neuropathology       Date:  2001-12       Impact factor: 1.906

2.  Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions.

Authors:  J Woulfe; A Kertesz; D G Munoz
Journal:  Acta Neuropathol       Date:  2001-07       Impact factor: 17.088

Review 3.  Frontotemporal lobar degeneration--tau as a pied piper?

Authors:  Markus Tolnay; Alphonse Probst
Journal:  Neurogenetics       Date:  2002-10       Impact factor: 2.660

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Correlations between the morphology of diffuse and primitive beta-amyloid (A beta) deposits and the frequency of associated cells in Down's syndrome.

Authors:  R A Armstrong
Journal:  Neuropathol Appl Neurobiol       Date:  1996-12       Impact factor: 8.090

Review 6.  Staging of Alzheimer-related cortical destruction.

Authors:  H Braak; E Braak; J Bohl
Journal:  Eur Neurol       Date:  1993       Impact factor: 1.710

Review 7.  Quantifying the pathology of neurodegenerative disorders: quantitative measurements, sampling strategies and data analysis.

Authors:  R A Armstrong
Journal:  Histopathology       Date:  2003-06       Impact factor: 5.087

8.  Cortical ubiquitin-positive inclusions in frontotemporal dementia without motor neuron disease: a quantitative immunocytochemical study.

Authors:  Enikö Kövari; Gabriel Gold; Panteleimon Giannakopoulos; Constantin Bouras
Journal:  Acta Neuropathol       Date:  2004-05-28       Impact factor: 17.088

Review 9.  Heterogeneity in senile dementia of the Alzheimer type: individual differences, progressive deterioration or clinical sub-types?

Authors:  K Ritchie; J Touchon
Journal:  J Clin Epidemiol       Date:  1992-12       Impact factor: 6.437

10.  alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease.

Authors:  Nigel J Cairns; Victoria Zhukareva; Kunihiro Uryu; Bin Zhang; Eileen Bigio; Ian R A Mackenzie; Marla Gearing; Charles Duyckaerts; Hideaki Yokoo; Yoichi Nakazato; Evelyn Jaros; Robert H Perry; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

View more
  25 in total

1.  A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease.

Authors:  Richard A Armstrong; Paul T Kotzbauer; Joel S Perlmutter; Meghan C Campbell; Kyle M Hurth; Robert E Schmidt; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2013-08-31       Impact factor: 3.575

2.  Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases.

Authors:  Steven E Arnold; Jon B Toledo; Dina H Appleby; Sharon X Xie; Li-San Wang; Young Baek; David A Wolk; Edward B Lee; Bruce L Miller; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Comp Neurol       Date:  2013-12-15       Impact factor: 3.215

3.  Frontal cortex neuropathology in dementia pugilistica.

Authors:  Tommy Saing; Malcolm Dick; Peter T Nelson; Ronald C Kim; David H Cribbs; Elizabeth Head
Journal:  J Neurotrauma       Date:  2012-04-10       Impact factor: 5.269

4.  TDP-43 variants of frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  J Mol Neurosci       Date:  2011-05-24       Impact factor: 3.444

5.  Laminar degeneration of frontal and temporal cortex in Parkinson disease dementia.

Authors:  Richard A Armstrong
Journal:  Neurol Sci       Date:  2017-02-08       Impact factor: 3.307

6.  Laminar distribution of the pathological changes in sporadic frontotemporal lobar degeneration with transactive response (TAR) DNA-binding protein of 43 kDa (TDP-43) proteinopathy: a quantitative study using polynomial curve fitting.

Authors:  R A Armstrong; R L Hamilton; I R A Mackenzie; J Hedreen; N J Cairns
Journal:  Neuropathol Appl Neurobiol       Date:  2013-06       Impact factor: 8.090

Review 7.  Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects.

Authors:  Glenda Halliday; Eileen H Bigio; Nigel J Cairns; Manuela Neumann; Ian R A Mackenzie; David M A Mann
Journal:  Acta Neuropathol       Date:  2012-08-10       Impact factor: 17.088

8.  Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3β.

Authors:  Xue Gao; Alvin P Joselin; Lei Wang; Amar Kar; Payal Ray; Andrew Bateman; Alison M Goate; Jane Y Wu
Journal:  Protein Cell       Date:  2010-07-07       Impact factor: 14.870

9.  Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders.

Authors:  Richard A Armstrong; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2015-05-01       Impact factor: 3.575

10.  Spatial patterns of TDP-43 neuronal cytoplasmic inclusions (NCI) in fifteen cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).

Authors:  Richard A Armstrong; Nigel J Cairns
Journal:  Neurol Sci       Date:  2011-06-07       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.